Investment Rating - The industry investment rating is maintained at "Outperform the Market - A" [5] Core Insights - The chemical industry is at the bottom of a four-year down cycle, with indicators suggesting it has nearly bottomed out, and 2026 is expected to be a turning point for the cycle [17] - The price index for Chinese chemical products (CCPI) was reported at 3930 points on December 31, 2025, a 39% decrease from the peak in 2021, indicating the industry is in a historically low range [17] - The net profit of the basic chemical sector for the first three quarters of 2025 was 112.7 billion yuan, a year-on-year increase of 7.5%, showing initial signs of stabilization [17] - Capital expenditure in the industry has decreased by 18.3% year-on-year, marking seven consecutive quarters of negative growth since Q4 2023, indicating the end of the supply expansion phase [17] Summary by Sections 1. Core Views - The chemical industry is experiencing a significant shift, with European chemical companies reducing capacity due to high energy costs and environmental compliance pressures, while Chinese companies are rapidly gaining market share due to cost advantages [18] - In the first eight months of 2025, 60% of monitored chemical products had export volumes in the top 80% of the last six years, with 40% in the top 100% [18] - The report suggests focusing on leading chemical companies with cost advantages, such as Wanhua Chemical, Hualu Hengsheng, and others [18] 2. Industry Performance - The basic chemical industry index rose by 2.3% in the week of March 20-27, outperforming the Shanghai Composite Index by 3.4 percentage points [25] - Year-to-date, the basic chemical industry index has increased by 9.1%, surpassing the Shanghai Composite Index by 10.5 percentage points [25] 3. Stock Performance - Among 424 stocks in the basic chemical sector, 246 stocks rose, while 171 fell during the week [31] - The top gainers included Jinmei Technology (+36.3%) and Foshan Plastics (+24.5%), while the biggest losers included Wanlang Magnetic Plastic (-12.4%) and Sanfangxiang (-12.2%) [31][32] 4. Key News and Company Announcements - AnDuoMai A reported a revenue of 28.945 billion yuan for 2025, a decrease of 1.84% year-on-year, with a net profit attributable to shareholders of -1.046 billion yuan, an increase of 63.98% year-on-year [34] - ST Shenhua reported a revenue of 5.610 billion yuan for 2025, an increase of 11.76% year-on-year, with a net profit attributable to shareholders of -0.1 billion yuan, an increase of 93.51% year-on-year [34]

证券代码：301022 证券简称：海泰科 公告编号：2026-012 青岛海泰科模塑科技股份有限公司 关于控股股东、实际控制人及其一致行动人权益变动触及 5%整数倍 暨披露简式权益变动报告书的提示性公告 公司控股股东、实际控制人孙文强先生及其一致行动人王纪学先生保证向本公司 提供的信息内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 1、本次权益变动主要系：1）因公司可转换公司债券转股使公司总股本增加，导 致信息披露义务人持股比例被动稀释；2）因完成 2023 年限制性股票激励计划第二个 归属期归属的股票登记使公司总股本增加，导致信息披露义务人持股数量增加、持股 比例被动稀释；3）信息披露义务人按照之前已披露的股份减持计划实施减持导致权 益变动。本次权益变动不触及要约收购。 2、本次权益变动前，信息披露义务人合计持有公司股份 40,830,387 股，占当时 公司总股本的 44.3638%。本次权益变动后，信息披露义务人合计持有公司股份 39,793,567 股，占公司总股本的 39.9999%，合计持股比例减少 4.3 ...

股票简称：海泰科 股票代码：301022 青岛海泰科模塑科技股份有限公司 简式权益变动报告书 上市公司名称：青岛海泰科模塑科技股份有限公司 股票上市地点：深圳证券交易所 信息披露义务人 1：孙文强先生 住所：山东省青岛市 通讯地址：山东省青岛市城阳区棘洪滩街道锦盛二路 66 号 信息披露义务人 2：王纪学先生 住所：山东省青岛市 通讯地址：山东省青岛市城阳区棘洪滩街道锦盛二路 66 号 股份变动性质：股份减少、持股比例下降（股本变动导致的持股比例被动变化、 股权激励归属、集中竞价和大宗交易减持） 签署日期：2026年3月19日 信息披露义务人声明 一、信息披露义务人依据《中华人民共和国公司法》《中华人民共和国证券法》 《上市公司收购管理办法》《公开发行证券的公司信息披露内容与格式准则第 15 号— —权益变动报告书》及相关的法律、法规编写本报告书。 二、信息披露义务人签署本报告书已获得必要的授权和批准。 三、依据《中华人民共和国证券法》《上市公司收购管理办法》《公开发行证券 的公司信息披露内容与格式准则第 15 号——权益变动报告书》的规定，本报告书已全 面披露信息披露义务人在青岛海泰科模塑科技股份有限公司中 ...

证券代码：301022 证券简称：海泰科 公告编号：2026-011 青岛海泰科模塑科技股份有限公司 青岛海泰科模塑科技股份有限公司（以下简称"公司"）于 2025 年 4 月 23 日召开了 第二届董事会第二十九次会议、第二届监事会第二十四次会议，审议通过了《关于使用 暂时闲置募集资金及自有资金进行现金管理的议案》，同意公司及全资子公司在确保不影 响募集资金投资项目建设、不影响正常生产经营及确保资金安全的情况下，使用不超过 人民币 35,000.00 万元的暂时闲置募集资金和不超过人民币 10,000.00 万元的自有资金进 行现金管理，使用期限自董事会审议通过之日起 12 个月内有效，上述额度可以由公司使 用，亦可以由公司的全资子公司使用，但应予以合并计算。本次额度生效后将覆盖前次 授权额度，在前述额度和期限范围内，资金可循环滚动使用。本事项在董事会审议权限 范围内，无需提交公司股东会审议。具体详见公司于 2025 年 4 月 24 日在巨潮资讯网 （www.cninfo.com.cn）披露的《关于使用暂时闲置募集资金及自有资金进行现金管理的 公告》（公告编号：2025-045）。 近日，公司使用暂时闲置 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 证券代码：301022 证券简称：海泰科 公告编号：2026-010 青岛海泰科模塑科技股份有限公司 关于使用暂时闲置募集资金进行现金管理到期赎回并继续进行现 金管理的进展公告 青岛海泰科模塑科技股份有限公司（以下简称"公司"）于 2025 年 4 月 23 日 召开了第二届董事会第二十九次会议、第二届监事会第二十四次会议，审议通过了 《关于使用暂时闲置募集资金及自有资金进行现金管理的议案》，同意公司及全资 子公司在确保不影响募集资金投资项目建设、不影响正常生产经营及确保资金安全 的情况下，使用不超过人民币 35,000.00 万元的暂时闲置募集资金和不超过人民币 10,000.00 万元的自有资金进行现金管理，使用期限自董事会审议通过之日起 12 个 月内有效，上述额度可以由公司使用，亦可以由公司的全资子公司使用，但应予以 合并计算。本次额度生效后将覆盖前次授权额度，在前述额度和期限范围内，资金 可循环滚动使用。本事项在董事会审议权限范围内，无需提交公司股东会审议。具 体详见公司于 2025 年 4 月 24 ...

Investment Rating - The report maintains a "Recommended" investment rating for the humanoid robot industry, indicating that the industry index is expected to outperform the benchmark index by more than 10% [6]. Core Insights - The humanoid robot concept index increased by 2.06% from February 22 to February 27, 2026, outperforming the CSI 300 index by 0.98 percentage points. Year-to-date, the humanoid robot index has risen by 7.52%, surpassing the CSI 300 index by 5.77 percentage points [11][15]. - Key developments include the release of China's first national humanoid robot and embodied intelligence standard system, which marks a new phase of standardized development in the industry [18]. - Significant financing activities were reported, including several companies securing substantial investments, indicating strong market interest and growth potential in the humanoid robotics sector [20][21][22]. Weekly Market Review - The humanoid robot index saw a weekly increase of 2.06%, with notable individual stock performances such as Andar Intelligent rising by 37.86% and Tianqi Co., Ltd. declining by 11.84% [11][15]. - The report highlights the performance of the humanoid robot index against the broader market, showcasing its resilience and growth trajectory [11][12]. Weekly Hotspot Review Policy Developments - The first national standard for humanoid robots and embodied intelligence was officially released, covering the entire industry chain and lifecycle, which is expected to facilitate standardized development [18]. - Shanghai is focusing on creating a comprehensive fund matrix to support emerging industries, including humanoid robotics, and aims to establish benchmark application scenarios for new technologies [19]. Product and Technology Iteration - New product launches include the Unitree As2 quadruped robot and the Honor Robot Phone, showcasing advancements in humanoid robotics technology [20]. - BMW has initiated pilot projects integrating humanoid robots into its production lines, demonstrating practical applications and value creation in real-world manufacturing environments [4]. Investment and Financing - Significant financing rounds were reported, including a multi-billion yuan investment in Self-Variable Robotics, which has become the highest-valued company in the embodied intelligence sector for 2026 [21]. - NIO's chip subsidiary secured over 2.2 billion yuan in financing, enhancing its capabilities in high-end chip development for autonomous driving and humanoid robotics [21]. - Qianxun Intelligent completed nearly 2 billion yuan in financing, with a valuation exceeding 10 billion yuan, indicating strong investor confidence in the sector [22]. Key Company Announcements - Haitai Technology has received small batch orders from humanoid robot clients, indicating initial market traction [23]. - Green's Harmonics reported a 122.40% year-on-year increase in net profit for 2025, attributed to the recovery of the industrial robot market and significant growth in its embodied intelligence robotics business [24].

Group 1 - The core viewpoint of the article is that Haitai Technology (301022) is actively participating in the restructuring plan of High-end Automobile as a creditor, aiming to maximize the interests of the company and its shareholders [1] - The company will handle undelivered products based on the progress of the restructuring, contractual agreements, and mutual negotiations to protect its legal rights [1] - Specific updates regarding the restructuring will be provided through official company announcements [1]

Core Insights - The industry is transitioning from the conceptual phase of humanoid robots to a commercial validation year in 2026, marked by actual orders and mass production [3][6] Company Developments - Haitai Technology has received small batch orders from humanoid robot clients, but emphasizes that the products have not yet been delivered and the order amount is minor, contributing little to total revenue [1][3] - Haozhi Electromechanical has sent samples of its core products, including harmonic reducers and joint modules, to some humanoid robot manufacturers, but notes that the sales revenue from these core components is still small and has not significantly impacted the company's performance [1][2] - Lens Technology has established a vertically integrated manufacturing platform, delivering products to several leading robot clients, including humanoid and quadruped robots, as well as key components like joint modules and six-dimensional force sensors, with a leading shipment scale in the industry [4][5] - Lichong Group has signed a long-term strategic procurement agreement with Weijing Intelligent to supply 5,000 sets of humanoid robot components over the next five years, with a contract value of approximately 75 million yuan, which includes assembly and supporting services [2][5] - Kingood Co. has made progress in the robotics field, securing multiple mass production orders for robot structural components based on its independently developed "Avatar Ni Microalloy" material, marking the commercialization of new material technology in the robotics sector [2][5]

Core Viewpoint - The company emphasizes that the recent share reduction by the controlling shareholder is a personal financial arrangement and does not reflect a lack of confidence in the company's development [1] Group 1 - The company acknowledges investors' concerns regarding stock prices and assures that the reduction is compliant and transparent [1] - The company has communicated market concerns to the controlling shareholder, urging careful consideration of market impact during the reduction process [1] - The company commits to focusing on operational excellence to deliver stable performance and returns to investors [1]

Core Viewpoint - The company, Haitai Technology, has not yet expanded its product applications into the medical and aviation sectors, as confirmed in a response to an investor inquiry [1] Group 1 - An investor inquired whether the company's products have been developed for use in medical and aviation scenarios [1] - The company responded that there are currently no applications of its products in the mentioned industries [1] - The company expressed gratitude for the investor's interest in its developments [1]